How do I prescribe and manage mIDH inhibitors in patients with IDH-mutant glioma?

Neurooncol Pract. 2024 Dec 3;12(Suppl 1):i19-i25. doi: 10.1093/nop/npae112. eCollection 2025 Feb.

Abstract

Recent interest has been in using mIDH inhibitors in patients with IDH-mutant gliomas. This review paper summarizes the indications, side effects, recommended dosing, and management for patients on ivosidenib and vorasidenib.

Keywords: IDH inhibitor; glioma; ivosidenib; prescribing; vorasidenib.

Publication types

  • Review